$CG
Carlyle Group Inc. Stock $cg

$cg Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000152716623000064 Filed on May 04, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$462.1M	$859.0M
YoY Change	-55.95%	-45.69%
Cost Of Revenue	$40.60M	$229.1M
YoY Change	-85.21%	-48.09%
Gross Profit	$421.5M	$629.9M
YoY Change	-45.58%	-44.77%
Gross Profit Margin	91.21%	73.33%
Selling, General & Admin	$463.6M	$429.2M
YoY Change	5.8%	6.82%
% of Gross Profit	109.99%	68.14%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$44.10M	$44.00M
YoY Change	8.89%	126.8%
% of Gross Profit	10.46%	6.99%
Operating Expenses	$496.4M	$462.0M
YoY Change	6.05%	13.51%
Operating Profit	-$74.90M	$167.9M
YoY Change	-124.45%	-77.11%
Interest Expense	$4.900M	$29.70M
YoY Change	-81.78%	6.83%
% of Operating Profit		17.69%
Other Income/Expense, Net	$0.00	-$100.0K
YoY Change	-100.0%	-66.67%
Pretax Income	-$70.00M	$159.6M
YoY Change	-123.36%	-78.51%
Income Tax	-$7.300M	$34.30M
% Of Pretax Income		21.49%
Net Earnings	-$98.40M	$100.7M
YoY Change	-140.1%	-82.38%
Net Earnings / Revenue	-21.29%	11.72%
Basic Earnings Per Share	-$0.27	$0.28
Diluted Earnings Per Share	-$0.27	$0.28
COMMON SHARES
Basic Shares Outstanding	362.1M shares	364.2M shares
Diluted Shares Outstanding	361.3M shares	365.4M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.407B	$1.239B
YoY Change	-8.63%	-15.09%
Cash & Equivalents	$1.407B	$1.010B
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$116.7M	$499.3M
Other Receivables	$605.8M	$100.6M
Total Short-Term Assets	$2.129B	$1.839B
YoY Change	-0.98%	-6.44%
LONG-TERM ASSETS
Property, Plant & Equipment	$498.4M	$141.8M
YoY Change	260.12%	-2.34%
Goodwill	$104.0M	$104.0M
YoY Change	718.9%	693.89%
Intangibles
YoY Change
Long-Term Investments	$11.37B	$2.916B
YoY Change	312.03%	9.92%
Other Assets	$19.60M	$30.90M
YoY Change	12.64%	71.67%
Total Long-Term Assets	$19.25B	$19.44B
YoY Change	-0.12%	-1.7%
TOTAL ASSETS
Total Short-Term Assets	$2.129B	$1.839B
Total Long-Term Assets	$19.25B	$19.44B
Total Assets	$21.38B	$21.27B
YoY Change	-0.2%	-2.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$327.5M	$304.8M
YoY Change	3.97%	-16.58%
Accrued Expenses	$4.352B	$4.430B
YoY Change	-14.72%	-13.27%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$63.40M	$33.90M
YoY Change	93.29%	-52.72%
Total Short-Term Liabilities	$5.038B	$5.083B
YoY Change	-12.92%	-13.52%
LONG-TERM LIABILITIES
Long-Term Debt	$8.710B	$2.276B
YoY Change	289.0%	0.91%
Other Long-Term Liabilities	$678.2M	$662.5M
YoY Change	-5.58%	-34.39%
Total Long-Term Liabilities	$9.388B	$2.276B
YoY Change	319.29%	0.91%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.038B	$5.083B
Total Long-Term Liabilities	$9.388B	$2.276B
Total Liabilities	$15.42B	$14.46B
YoY Change	2.83%	-5.98%
SHAREHOLDERS EQUITY
Retained Earnings	$2.993B	$3.281B
YoY Change	-9.58%	2.3%
Common Stock	$3.600M	$3.600M
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.964B	$6.175B
YoY Change
Total Liabilities & Shareholders Equity	$21.38B	$21.27B
YoY Change	-0.2%	-2.13%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$98.40M	$100.7M
YoY Change	-140.1%	-82.38%
Depreciation, Depletion And Amortization	$44.10M	$44.00M
YoY Change	8.89%	126.8%
Cash From Operating Activities	-$736.5M	-$112.5M
YoY Change	294.27%	-69.73%
INVESTING ACTIVITIES
Capital Expenditures	$19.60M	$12.90M
YoY Change	-484.31%	4.88%
Acquisitions
YoY Change
Other Investing Activities	$58.20M	-$81.00M
YoY Change
Cash From Investing Activities	$38.60M	-$93.90M
YoY Change	-856.86%	-85.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	544.5M	-$136.5M
YoY Change	126.5%	-17.02%
NET CHANGE
Cash From Operating Activities	-736.5M	-$112.5M
Cash From Investing Activities	38.60M	-$93.90M
Cash From Financing Activities	544.5M	-$136.5M
Net Change In Cash	-153.4M	-$334.6M
YoY Change	-416.29%	-71.75%
FREE CASH FLOW
Cash From Operating Activities	-$736.5M	-$112.5M
Capital Expenditures	$19.60M	$12.90M
Free Cash Flow	-$756.1M	-$125.4M
YoY Change	316.13%	-67.34%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Washington
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	DC
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001527166
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://www.carlyle.com/20230331#NetInvestmentGainsLossesOfConsolidatedFunds
CY2023Q1	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://www.carlyle.com/20230331#NetInvestmentGainsLossesOfConsolidatedFunds
CY2020Q1	cg	Termination Of Tax Receivable Agreement Term Of Annual Installments TerminationOfTaxReceivableAgreementTermOfAnnualInstallments	P5Y
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-35538
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Carlyle Group Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-2832612
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1001 Pennsylvania Avenue, NW
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20004-2505
CY2023Q1	dei	City Area Code CityAreaCode	202
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	729-5626
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	362114917	shares
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1010100000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1360700000	usd
CY2023Q1	cg	Cash And Cash Equivalents At Carrying Value Held At Consolidated Funds CashAndCashEquivalentsAtCarryingValueHeldAtConsolidatedFunds	228800000	usd
CY2022Q4	cg	Cash And Cash Equivalents At Carrying Value Held At Consolidated Funds CashAndCashEquivalentsAtCarryingValueHeldAtConsolidatedFunds	209000000.0	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	16800000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	800000	usd
CY2023Q1	cg	Corporate Treasury Investments CorporateTreasuryInvestments	102000000.0	usd
CY2022Q4	cg	Corporate Treasury Investments CorporateTreasuryInvestments	20000000.0	usd
CY2023Q1	cg	Accrued Performance Based Capital Allocation AccruedPerformanceBasedCapitalAllocation	7134000000	usd
CY2022Q4	cg	Accrued Performance Based Capital Allocation AccruedPerformanceBasedCapitalAllocation	7117700000	usd
CY2023Q1	us-gaap	Investments Investments	10784100000	usd
CY2022Q4	us-gaap	Investments Investments	10767900000	usd
CY2023Q1	cg	Investments Of Consolidated Funds InvestmentsOfConsolidatedFunds	7067300000	usd
CY2022Q4	cg	Investments Of Consolidated Funds InvestmentsOfConsolidatedFunds	6894400000	usd
CY2023Q1	us-gaap	Due From Affiliates DueFromAffiliates	499300000	usd
CY2022Q4	us-gaap	Due From Affiliates DueFromAffiliates	579400000	usd
CY2023Q1	cg	Due From Affiliates Of Consolidated Funds DueFromAffiliatesOfConsolidatedFunds	100600000	usd
CY2022Q4	cg	Due From Affiliates Of Consolidated Funds DueFromAffiliatesOfConsolidatedFunds	101900000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	141800000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	139900000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	331500000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	337000000.0	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	111100000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	78400000	usd
CY2023Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	866400000	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	897800000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	14100000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	15800000	usd
CY2023Q1	us-gaap	Assets Assets	21273900000	usd
CY2022Q4	us-gaap	Assets Assets	21403000000	usd
CY2023Q1	us-gaap	Loans Payable LoansPayable	2275600000	usd
CY2022Q4	us-gaap	Loans Payable LoansPayable	2271700000	usd
CY2023Q1	cg	Loan Payable To Affiliate Of Consolidated Funds LoanPayableToAffiliateOfConsolidatedFunds	6085900000	usd
CY2022Q4	cg	Loan Payable To Affiliate Of Consolidated Funds LoanPayableToAffiliateOfConsolidatedFunds	5905200000	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	304800000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	369200000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	3894200000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	4320900000	usd
CY2023Q1	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	314100000	usd
CY2022Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	362500000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	411700000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	126400000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	389500000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	402700000	usd
CY2023Q1	cg	Other Liabilities Of Consolidated Funds OtherLiabilitiesOfConsolidatedFunds	250800000	usd
CY2022Q4	cg	Other Liabilities Of Consolidated Funds OtherLiabilitiesOfConsolidatedFunds	279300000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	494900000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	502900000	usd
CY2023Q1	cg	Accrued Giveback Obligations AccruedGivebackObligations	40900000	usd
CY2022Q4	cg	Accrued Giveback Obligations AccruedGivebackObligations	40900000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	14462400000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	14581700000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	3000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	362056444	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	362056444	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	362298650	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	362298650	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	3600000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	3600000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3195500000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3138500000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3280900000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3401100000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-305200000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-322200000	usd
CY2022Q1	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	1700000	shares
CY2023Q1	us-gaap	Minority Interest MinorityInterest	636700000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	600300000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6811500000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6821300000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21273900000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21403000000	usd
CY2023Q1	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	172500000	usd
CY2022Q1	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	1029800000	usd
CY2023Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	44000000.0	usd
CY2022Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	25800000	usd
CY2023Q1	cg	Interest And Other Income Of Consolidated Funds InterestAndOtherIncomeOfConsolidatedFunds	121900000	usd
CY2022Q1	cg	Interest And Other Income Of Consolidated Funds InterestAndOtherIncomeOfConsolidatedFunds	61700000	usd
CY2023Q1	us-gaap	Revenues Revenues	859000000.0	usd
CY2022Q1	us-gaap	Revenues Revenues	1581800000	usd
CY2023Q1	us-gaap	Salaries And Wages SalariesAndWages	260200000	usd
CY2022Q1	us-gaap	Salaries And Wages SalariesAndWages	254300000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	54400000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	39700000	usd
CY2023Q1	cg	Performance Allocations And Incentive Fee Expense PerformanceAllocationsAndIncentiveFeeExpense	105700000	usd
CY2022Q1	cg	Performance Allocations And Incentive Fee Expense PerformanceAllocationsAndIncentiveFeeExpense	370700000	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	420300000	usd
CY2022Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	664700000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	159200000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	106300000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	29700000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	27800000	usd
CY2023Q1	cg	Interest And Other Expenses Of Consolidated Funds InterestAndOtherExpensesOfConsolidatedFunds	93700000	usd
CY2022Q1	cg	Interest And Other Expenses Of Consolidated Funds InterestAndOtherExpensesOfConsolidatedFunds	42800000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-100000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-300000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	703000000.0	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	841900000	usd
CY2023Q1	cg	Net Investment Gains Losses Of Consolidated Funds NetInvestmentGainsLossesOfConsolidatedFunds	3600000	usd
CY2022Q1	cg	Net Investment Gains Losses Of Consolidated Funds NetInvestmentGainsLossesOfConsolidatedFunds	2800000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	159600000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	742700000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	34300000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	147900000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	125300000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	594800000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	24600000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	23200000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	100700000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	571600000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.28
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.60
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.28
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.57
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	362944260	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	357574838	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	365357833	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	363010282	shares
CY2023Q1	us-gaap	Profit Loss ProfitLoss	125300000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	594800000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	19800000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-39800000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax	-300000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax	1800000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax	-100000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax	300000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	20000000.0	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-41300000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	145300000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	553500000	usd
CY2023Q1	cg	Comprehensive Income Loss Net Of Tax Attributable To Noncontrolling Interest In Consolidated Entities ComprehensiveIncomeLossNetOfTaxAttributableToNoncontrollingInterestInConsolidatedEntities	27600000	usd
CY2022Q1	cg	Comprehensive Income Loss Net Of Tax Attributable To Noncontrolling Interest In Consolidated Entities ComprehensiveIncomeLossNetOfTaxAttributableToNoncontrollingInterestInConsolidatedEntities	17400000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	117700000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	536100000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6821300000	usd
CY2023Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	100300000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	54800000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	0	usd
CY2023Q1	cg	Noncontrolling Interest Increase For Contributions From Noncontrolling Interest Holders NoncontrollingInterestIncreaseForContributionsFromNoncontrollingInterestHolders	18700000	usd
CY2023Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	128300000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	125300000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	19800000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-200000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6811500000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5706200000	usd
CY2022Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	80400000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	39000000.0	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	31300000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	194500000	usd
CY2022Q1	cg	Noncontrolling Interest Increase For Contributions From Noncontrolling Interest Holders NoncontrollingInterestIncreaseForContributionsFromNoncontrollingInterestHolders	146800000	usd
CY2022Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	236600000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	594800000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-39800000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	1500000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6354300000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	125300000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	594800000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	44000000.0	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19400000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	54400000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	39700000	usd
CY2023Q1	cg	Non Cash Performance Allocations And Incentive Fees Gain Loss NonCashPerformanceAllocationsAndIncentiveFeesGainLoss	36700000	usd
CY2022Q1	cg	Non Cash Performance Allocations And Incentive Fees Gain Loss NonCashPerformanceAllocationsAndIncentiveFeesGainLoss	300800000	usd
CY2023Q1	cg	Unrealized Principal Investment Income Loss UnrealizedPrincipalInvestmentIncomeLoss	7700000	usd
CY2022Q1	cg	Unrealized Principal Investment Income Loss UnrealizedPrincipalInvestmentIncomeLoss	315300000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-10800000	usd
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-5300000	usd
CY2023Q1	cg	Realized Unrealized Gain Loss On Investments Of Consolidated Funds RealizedUnrealizedGainLossOnInvestmentsOfConsolidatedFunds	145000000.0	usd
CY2022Q1	cg	Realized Unrealized Gain Loss On Investments Of Consolidated Funds RealizedUnrealizedGainLossOnInvestmentsOfConsolidatedFunds	-43400000	usd
CY2023Q1	cg	Realized Unrealized Gain Loss From Loans Payable Of Consolidated Funds RealizedUnrealizedGainLossFromLoansPayableOfConsolidatedFunds	-141400000	usd
CY2022Q1	cg	Realized Unrealized Gain Loss From Loans Payable Of Consolidated Funds RealizedUnrealizedGainLossFromLoansPayableOfConsolidatedFunds	46200000	usd
CY2023Q1	cg	Purchases Of Investments By Consolidated Funds PurchasesOfInvestmentsByConsolidatedFunds	386600000	usd
CY2022Q1	cg	Purchases Of Investments By Consolidated Funds PurchasesOfInvestmentsByConsolidatedFunds	1025900000	usd
CY2023Q1	cg	Proceeds From Sale And Settlements Of Investments By Consolidated Funds ProceedsFromSaleAndSettlementsOfInvestmentsByConsolidatedFunds	332500000	usd
CY2022Q1	cg	Proceeds From Sale And Settlements Of Investments By Consolidated Funds ProceedsFromSaleAndSettlementsOfInvestmentsByConsolidatedFunds	1113700000	usd
CY2023Q1	cg	Non Cash Interest Income Net Of Consolidated Funds NonCashInterestIncomeNetOfConsolidatedFunds	3700000	usd
CY2022Q1	cg	Non Cash Interest Income Net Of Consolidated Funds NonCashInterestIncomeNetOfConsolidatedFunds	2700000	usd
CY2023Q1	cg	Increase Decrease In Cash And Cash Equivalents Held At Consolidated Funds IncreaseDecreaseInCashAndCashEquivalentsHeldAtConsolidatedFunds	20800000	usd
CY2022Q1	cg	Increase Decrease In Cash And Cash Equivalents Held At Consolidated Funds IncreaseDecreaseInCashAndCashEquivalentsHeldAtConsolidatedFunds	21100000	usd
CY2023Q1	cg	Increase Decrease Other Receivables Held At Consolidated Funds IncreaseDecreaseOtherReceivablesHeldAtConsolidatedFunds	-7100000	usd
CY2022Q1	cg	Increase Decrease Other Receivables Held At Consolidated Funds IncreaseDecreaseOtherReceivablesHeldAtConsolidatedFunds	6000000.0	usd
CY2023Q1	cg	Increase Decrease Other Liabilities Held At Consolidated Funds IncreaseDecreaseOtherLiabilitiesHeldAtConsolidatedFunds	-32800000	usd
CY2022Q1	cg	Increase Decrease Other Liabilities Held At Consolidated Funds IncreaseDecreaseOtherLiabilitiesHeldAtConsolidatedFunds	-34100000	usd
CY2023Q1	us-gaap	Payments For Purchase Of Securities Operating Activities PaymentsForPurchaseOfSecuritiesOperatingActivities	18500000	usd
CY2022Q1	us-gaap	Payments For Purchase Of Securities Operating Activities PaymentsForPurchaseOfSecuritiesOperatingActivities	307500000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Securities Operating Activities ProceedsFromSaleOfSecuritiesOperatingActivities	78600000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Securities Operating Activities ProceedsFromSaleOfSecuritiesOperatingActivities	158300000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	68600000	usd
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	5700000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	15100000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-110900000	usd
CY2023Q1	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-16900000	usd
CY2022Q1	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	9500000	usd
CY2023Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	33900000	usd
CY2022Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	39800000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-63900000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-14300000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-371900000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-580100000	usd
CY2023Q1	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-200000	usd
CY2022Q1	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-200000	usd
CY2023Q1	cg	Increase Decrease In Right Of Use Asset And Lease Liability IncreaseDecreaseInRightOfUseAssetAndLeaseLiability	-2800000	usd
CY2022Q1	cg	Increase Decrease In Right Of Use Asset And Lease Liability IncreaseDecreaseInRightOfUseAssetAndLeaseLiability	-2500000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	284700000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	254500000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-112500000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-371700000	usd
CY2023Q1	cg	Payments To Acquire Corporate Treasury Investments Net PaymentsToAcquireCorporateTreasuryInvestmentsNet	101100000	usd
CY2022Q1	cg	Payments To Acquire Corporate Treasury Investments Net PaymentsToAcquireCorporateTreasuryInvestmentsNet	0	usd
CY2023Q1	cg	Proceeds From Corporate Treasury Investments Net ProceedsFromCorporateTreasuryInvestmentsNet	20100000	usd
CY2022Q1	cg	Proceeds From Corporate Treasury Investments Net ProceedsFromCorporateTreasuryInvestmentsNet	0	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12900000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12300000	usd
CY2023Q1	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	0	usd
CY2022Q1	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	618400000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-93900000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-630700000	usd
CY2023Q1	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	1100000	usd
CY2022Q1	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	8900000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	40800000	usd
CY2023Q1	cg	Proceeds From Repayments Of Loans Payable Of Consolidated Funds ProceedsFromRepaymentsOfLoansPayableOfConsolidatedFunds	68700000	usd
CY2022Q1	cg	Proceeds From Repayments Of Loans Payable Of Consolidated Funds ProceedsFromRepaymentsOfLoansPayableOfConsolidatedFunds	-21800000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	118400000	usd
CY2022Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	89500000	usd
CY2023Q1	cg	Payment Of Deferred Consideration For Partnership Units PaymentOfDeferredConsiderationForPartnershipUnits	68800000	usd
CY2022Q1	cg	Payment Of Deferred Consideration For Partnership Units PaymentOfDeferredConsiderationForPartnershipUnits	68800000	usd
CY2023Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	18700000	usd
CY2022Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	146800000	usd
CY2023Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	9900000	usd
CY2022Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	147100000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	0	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	31300000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	100300000	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	80400000	usd
CY2023Q1	cg	Change In Due To From Affiliates Financing Activities ChangeInDueToFromAffiliatesFinancingActivities	-74600000	usd
CY2022Q1	cg	Change In Due To From Affiliates Financing Activities ChangeInDueToFromAffiliatesFinancingActivities	-33100000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-136500000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-164500000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8300000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-17400000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-334600000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1184300000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1361500000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2475100000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1026900000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1290800000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1010100000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1290200000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	16800000	usd
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	600000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1026900000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1290800000	usd
CY2023Q1	cg	Cash And Cash Equivalents At Carrying Value Held At Consolidated Funds CashAndCashEquivalentsAtCarryingValueHeldAtConsolidatedFunds	228800000	usd
CY2022Q1	cg	Cash And Cash Equivalents At Carrying Value Held At Consolidated Funds CashAndCashEquivalentsAtCarryingValueHeldAtConsolidatedFunds	168900000	usd
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023Q1	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	376500000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:6pt;margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make assumptions and estimates that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Management’s estimates are based on historical experiences and other factors, including expectations of future events that management believes to be reasonable under the circumstances. It also requires management to exercise judgment in the process of applying the Company’s accounting policies. Assumptions and estimates regarding the valuation of investments and their resulting impact on performance allocations and incentive fees involve a higher degree of judgment and complexity and these assumptions and estimates may be significant to the consolidated financial statements and the resulting impact on performance allocations and incentive fees. Actual results could differ from these estimates and such differences could be material.</span></div>
CY2023Q1	cg	Period For Management Fees Received By Partners From Initial Closing Date PeriodForManagementFeesReceivedByPartnersFromInitialClosingDate	P10Y
CY2023Q1	cg	Subsequent Period Management Fees Recognized After Called SubsequentPeriodManagementFeesRecognizedAfterCalled	P6M
CY2023Q1	cg	Annual Management Fee Rate For Interval Funds AnnualManagementFeeRateForIntervalFunds	0.010
CY2023Q1	cg	Management Fee Receivables ManagementFeeReceivables	169500000	usd
CY2022Q4	cg	Management Fee Receivables ManagementFeeReceivables	236900000	usd
CY2023Q1	cg	Transaction And Portfolio Advisory Fees Included In Fund Management Fees TransactionAndPortfolioAdvisoryFeesIncludedInFundManagementFees	13400000	usd
CY2022Q1	cg	Transaction And Portfolio Advisory Fees Included In Fund Management Fees TransactionAndPortfolioAdvisoryFeesIncludedInFundManagementFees	14600000	usd
CY2023Q1	cg	Performance Fees Allocation Percentage To Partnership PerformanceFeesAllocationPercentageToPartnership	0.20
CY2023Q1	cg	Accrued Giveback Obligations AccruedGivebackObligations	40900000	usd
CY2022Q4	cg	Accrued Giveback Obligations AccruedGivebackObligations	40900000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	109800000	usd
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	56500000	usd
CY2022Q4	cg	Accrued Performance Fees Due To Employees And Advisors Included In Accrued Compensation AccruedPerformanceFeesDueToEmployeesAndAdvisorsIncludedInAccruedCompensation	3600000000	usd
CY2023Q1	cg	Accrued Performance Fees Due To Employees And Advisors Included In Accrued Compensation AccruedPerformanceFeesDueToEmployeesAndAdvisorsIncludedInAccruedCompensation	3600000000	usd
CY2023Q1	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	288200000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-11800000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	6400000	usd
CY2023Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	7848400000	usd
CY2023Q1	us-gaap	Loans Payable Fair Value Disclosure LoansPayableFairValueDisclosure	5647900000	usd
CY2023Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	1600000	usd
CY2023Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	5649500000	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	7049300000	usd
CY2022Q4	us-gaap	Alternative Investment AlternativeInvestment	7577800000	usd
CY2022Q4	us-gaap	Loans Payable Fair Value Disclosure LoansPayableFairValueDisclosure	5491600000	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	3200000	usd
CY2022Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	5494800000	usd
CY2023Q1	cg	Accrued Performance Based Capital Allocation AccruedPerformanceBasedCapitalAllocation	7134000000	usd
CY2022Q4	cg	Accrued Performance Based Capital Allocation AccruedPerformanceBasedCapitalAllocation	7117700000	usd
CY2023Q1	cg	Equity Method Investment Excluding Performance Allocations EquityMethodInvestmentExcludingPerformanceAllocations	2915600000	usd
CY2022Q4	cg	Equity Method Investment Excluding Performance Allocations EquityMethodInvestmentExcludingPerformanceAllocations	2922000000	usd
CY2023Q1	cg	Principal Investments In Collateralized Loan Obligations PrincipalInvestmentsInCollateralizedLoanObligations	544800000	usd
CY2022Q4	cg	Principal Investments In Collateralized Loan Obligations PrincipalInvestmentsInCollateralizedLoanObligations	526100000	usd
CY2023Q1	cg	Principal Investments In Other Investments PrincipalInvestmentsInOtherInvestments	189700000	usd
CY2022Q4	cg	Principal Investments In Other Investments PrincipalInvestmentsInOtherInvestments	202100000	usd
CY2023Q1	us-gaap	Investments Investments	10784100000	usd
CY2022Q4	us-gaap	Investments Investments	10767900000	usd
CY2023Q1	cg	Accrued Performance Fees AccruedPerformanceFees	7134000000	usd
CY2022Q4	cg	Accrued Performance Fees AccruedPerformanceFees	7117700000	usd
CY2023Q1	cg	Number Of Partnerships Corporate Private Equity Funds Related To Accrued Performance Fees NumberOfPartnershipsCorporatePrivateEquityFundsRelatedToAccruedPerformanceFees	2	financingvehicle
CY2022Q4	cg	Number Of Partnerships Corporate Private Equity Funds Related To Accrued Performance Fees NumberOfPartnershipsCorporatePrivateEquityFundsRelatedToAccruedPerformanceFees	1	fund
CY2023Q1	cg	Accrued Giveback Obligations AccruedGivebackObligations	40900000	usd
CY2022Q4	cg	Accrued Giveback Obligations AccruedGivebackObligations	40900000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	2915600000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	2922000000	usd
CY2023Q1	cg	Amortization Period Of Basis Difference AmortizationPeriodOfBasisDifference	P10Y
CY2023Q1	cg	Percentage Of Carried Interest Income Allocated To Partnership For Future Carry Funds PercentageOfCarriedInterestIncomeAllocatedToPartnershipForFutureCarryFunds	0.475
CY2023Q1	us-gaap	Investment Income Net InvestmentIncomeNet	172500000	usd
CY2022Q1	us-gaap	Investment Income Net InvestmentIncomeNet	1029800000	usd
CY2023Q1	cg	Performance Allocation Investment Income Loss PerformanceAllocationInvestmentIncomeLoss	160800000	usd
CY2022Q1	cg	Performance Allocation Investment Income Loss PerformanceAllocationInvestmentIncomeLoss	710200000	usd
CY2023Q1	cg	Minimum Percent Of Aggregate Assets For Individual Investments With Fair Value MinimumPercentOfAggregateAssetsForIndividualInvestmentsWithFairValue	0.05
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	109800000	usd
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	56500000	usd
CY2023Q1	us-gaap	Other Income OtherIncome	12100000	usd
CY2022Q1	us-gaap	Other Income OtherIncome	5200000	usd
CY2023Q1	cg	Interest And Other Income Of Consolidated Funds InterestAndOtherIncomeOfConsolidatedFunds	121900000	usd
CY2022Q1	cg	Interest And Other Income Of Consolidated Funds InterestAndOtherIncomeOfConsolidatedFunds	61700000	usd
CY2023Q1	cg	Realized Unrealized Gain Loss From Investments Of Consolidated Funds RealizedUnrealizedGainLossFromInvestmentsOfConsolidatedFunds	145000000.0	usd
CY2022Q1	cg	Realized Unrealized Gain Loss From Investments Of Consolidated Funds RealizedUnrealizedGainLossFromInvestmentsOfConsolidatedFunds	-43400000	usd
CY2023Q1	cg	Realized Unrealized Gains Losses From Collateralized Loan Obligations Of Consolidated Funds RealizedUnrealizedGainsLossesFromCollateralizedLoanObligationsOfConsolidatedFunds	-141400000	usd
CY2022Q1	cg	Realized Unrealized Gains Losses From Collateralized Loan Obligations Of Consolidated Funds RealizedUnrealizedGainsLossesFromCollateralizedLoanObligationsOfConsolidatedFunds	46200000	usd
CY2023Q1	cg	Net Investment Gains Losses Of Consolidated Funds NetInvestmentGainsLossesOfConsolidatedFunds	3600000	usd
CY2022Q1	cg	Net Investment Gains Losses Of Consolidated Funds NetInvestmentGainsLossesOfConsolidatedFunds	2800000	usd
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-17400000	usd
CY2022Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	2700000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	162400000	usd
CY2022Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-46100000	usd
CY2023Q1	cg	Realized Unrealized Gains Losses From Investments Of Consolidated Funds RealizedUnrealizedGainsLossesFromInvestmentsOfConsolidatedFunds	145000000.0	usd
CY2022Q1	cg	Realized Unrealized Gains Losses From Investments Of Consolidated Funds RealizedUnrealizedGainsLossesFromInvestmentsOfConsolidatedFunds	-43400000	usd
CY2023Q1	us-gaap	Finite Lived Contractual Rights Gross FiniteLivedContractualRightsGross	921700000	usd
CY2022Q4	us-gaap	Finite Lived Contractual Rights Gross FiniteLivedContractualRightsGross	920200000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	159300000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	126300000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	762400000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	793900000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	104000000.0	usd
CY2022Q4	us-gaap	Goodwill Goodwill	103900000	usd
CY2023Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	866400000	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	897800000	usd
CY2023Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2022Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	4000000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	32800000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4900000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	98600000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	131500000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	131400000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	131300000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	121200000	usd
CY2023Q1	cg	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	148400000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	762400000	usd
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	2300400000	usd
CY2023Q1	us-gaap	Notes And Loans Payable NotesAndLoansPayable	2275600000	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	2296700000	usd
CY2022Q4	us-gaap	Notes And Loans Payable NotesAndLoansPayable	2271700000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	17200000	usd
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	17200000	usd
CY2023Q1	cg	Fair Value Of Collateralized Loan Obligation Assets FairValueOfCollateralizedLoanObligationAssets	6300000000	usd
CY2022Q4	cg	Fair Value Of Collateralized Loan Obligation Assets FairValueOfCollateralizedLoanObligationAssets	6200000000	usd
CY2023Q1	cg	Accrued Performance Fees Due To Employees And Advisors Included In Accrued Compensation AccruedPerformanceFeesDueToEmployeesAndAdvisorsIncludedInAccruedCompensation	3637000000	usd
CY2022Q4	cg	Accrued Performance Fees Due To Employees And Advisors Included In Accrued Compensation AccruedPerformanceFeesDueToEmployeesAndAdvisorsIncludedInAccruedCompensation	3625300000	usd
CY2023Q1	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	132800000	usd
CY2022Q4	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	466600000	usd
CY2023Q1	cg	Employment Based Contingent Cash Consideration EmploymentBasedContingentCashConsideration	2400000	usd
CY2022Q4	cg	Employment Based Contingent Cash Consideration EmploymentBasedContingentCashConsideration	76500000	usd
CY2023Q1	us-gaap	Defined Benefit Pension Plan Liabilities Current DefinedBenefitPensionPlanLiabilitiesCurrent	7300000	usd
CY2022Q4	us-gaap	Defined Benefit Pension Plan Liabilities Current DefinedBenefitPensionPlanLiabilitiesCurrent	9500000	usd
CY2023Q1	us-gaap	Other Employee Related Liabilities Current And Noncurrent OtherEmployeeRelatedLiabilitiesCurrentAndNoncurrent	114700000	usd
CY2022Q4	us-gaap	Other Employee Related Liabilities Current And Noncurrent OtherEmployeeRelatedLiabilitiesCurrentAndNoncurrent	143000000.0	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	3894200000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	4320900000	usd
CY2023Q1	cg	Accrued Bonuses Make Whole Cash Incentive Awards Granted AccruedBonusesMakeWholeCashIncentiveAwardsGranted	4800000	usd
CY2023Q1	cg	Accrued Performance Allocations And Incentive Fee Related Compensation Not Yet Paid AccruedPerformanceAllocationsAndIncentiveFeeRelatedCompensationNotYetPaid	17700000	usd
CY2022Q4	cg	Accrued Performance Allocations And Incentive Fee Related Compensation Not Yet Paid AccruedPerformanceAllocationsAndIncentiveFeeRelatedCompensationNotYetPaid	26700000	usd
CY2023Q1	cg	Performance Fee Expense Realized PerformanceFeeExpenseRealized	103600000	usd
CY2022Q1	cg	Performance Fee Expense Realized PerformanceFeeExpenseRealized	137600000	usd
CY2023Q1	cg	Unrealized Gain Loss On Performance Revenues And Fees Compensation Expense UnrealizedGainLossOnPerformanceRevenuesAndFeesCompensationExpense	2100000	usd
CY2022Q1	cg	Unrealized Gain Loss On Performance Revenues And Fees Compensation Expense UnrealizedGainLossOnPerformanceRevenuesAndFeesCompensationExpense	233100000	usd
CY2023Q1	cg	Performance Allocations And Incentive Fee Expense PerformanceAllocationsAndIncentiveFeeExpense	105700000	usd
CY2022Q1	cg	Performance Allocations And Incentive Fee Expense PerformanceAllocationsAndIncentiveFeeExpense	370700000	usd
CY2023Q1	cg	Unfunded Commitment UnfundedCommitment	4175900000	usd
CY2023Q1	cg	Unfunded Commitment UnfundedCommitment	4200000000	usd
CY2023Q1	cg	Unfunded Commitment To Be Paid By Senior Executives And Professionals UnfundedCommitmentToBePaidBySeniorExecutivesAndProfessionals	3500000000	usd
CY2023Q1	cg	Unfunded Commitments Origination And Syndication Of Loans UnfundedCommitmentsOriginationAndSyndicationOfLoans	0	usd
CY2023Q1	cg	Accrued Giveback Obligations AccruedGivebackObligations	40900000	usd
CY2023Q1	cg	Giveback Obligation Receivable GivebackObligationReceivable	10000000	usd
CY2023Q1	cg	Amount Of Giveback Obligation Of Current And Former Related Parties AmountOfGivebackObligationOfCurrentAndFormerRelatedParties	18900000	usd
CY2023Q1	cg	Amount Of Net Accrued Giveback Obligation Of Subsidiary AmountOfNetAccruedGivebackObligationOfSubsidiary	22000000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2023Q1	cg	Lessee Operating Lease Option To Terminate Term LesseeOperatingLeaseOptionToTerminateTerm	P1Y
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	14100000	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	14000000.0	usd
CY2023Q1	us-gaap	Sublease Income SubleaseIncome	1500000	usd
CY2022Q1	us-gaap	Sublease Income SubleaseIncome	1500000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	12600000	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	12500000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	16300000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	16000000.0	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P10Y10M24D
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P11Y9M18D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.042
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.041
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	51400000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	65000000.0	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	61000000.0	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	58600000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	59200000	usd
CY2023Q1	cg	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	340000000.0	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	635200000	usd
CY2023Q1	cg	Lessee Operating Lease Lease Notyet Commenced Payments Due LesseeOperatingLeaseLeaseNotyetCommencedPaymentsDue	25800000	usd
CY2022Q4	cg	Management Fee Reimbursable Expenses And Other Receivables From Unconsolidated Funds And Affiliates ManagementFeeReimbursableExpensesAndOtherReceivablesFromUnconsolidatedFundsAndAffiliates	511100000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	114500000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	494900000	usd
CY2023Q1	cg	Number Of Employees Serving On Board Of Directors NumberOfEmployeesServingOnBoardOfDirectors	2	employee
CY2023Q1	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	87500000	usd
CY2023Q1	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	35000000	usd
CY2023Q1	cg	Accrued Incentive Fees Related Party AccruedIncentiveFeesRelatedParty	17500000	usd
CY2022Q4	cg	Accrued Incentive Fees Related Party AccruedIncentiveFeesRelatedParty	16400000	usd
CY2023Q1	cg	Giveback Obligation Receivable GivebackObligationReceivable	10000000.0	usd
CY2022Q4	cg	Giveback Obligation Receivable GivebackObligationReceivable	10400000	usd
CY2023Q1	cg	Notes Receivable And Accrued Interest From Affiliates NotesReceivableAndAccruedInterestFromAffiliates	32900000	usd
CY2022Q4	cg	Notes Receivable And Accrued Interest From Affiliates NotesReceivableAndAccruedInterestFromAffiliates	41500000	usd
CY2023Q1	cg	Management Fee Reimbursable Expenses And Other Receivables From Unconsolidated Funds And Affiliates ManagementFeeReimbursableExpensesAndOtherReceivablesFromUnconsolidatedFundsAndAffiliates	438900000	usd
CY2023Q1	us-gaap	Due From Affiliates DueFromAffiliates	499300000	usd
CY2022Q4	us-gaap	Due From Affiliates DueFromAffiliates	579400000	usd
CY2023Q1	us-gaap	Receivable With Imputed Interest Effective Yield Interest Rate ReceivableWithImputedInterestEffectiveYieldInterestRate	0.0702
CY2023Q1	cg	Due To Affiliates Of Consolidated Funds DueToAffiliatesOfConsolidatedFunds	11600000	usd
CY2022Q4	cg	Due To Affiliates Of Consolidated Funds DueToAffiliatesOfConsolidatedFunds	16400000	usd
CY2023Q1	cg	Due To Non Consolidated Affiliates DueToNonConsolidatedAffiliates	130900000	usd
CY2022Q4	cg	Due To Non Consolidated Affiliates DueToNonConsolidatedAffiliates	87100000	usd
CY2023Q1	cg	Amounts Owed Under Tax Receivable Agreement AmountsOwedUnderTaxReceivableAgreement	79600000	usd
CY2022Q4	cg	Amounts Owed Under Tax Receivable Agreement AmountsOwedUnderTaxReceivableAgreement	100000000.0	usd
CY2023Q1	cg	Due To Affiliate Deferred Consideration DueToAffiliateDeferredConsideration	65200000	usd
CY2022Q4	cg	Due To Affiliate Deferred Consideration DueToAffiliateDeferredConsideration	134400000	usd
CY2023Q1	cg	Due To Affiliates Other DueToAffiliatesOther	26800000	usd
CY2022Q4	cg	Due To Affiliates Other DueToAffiliatesOther	24600000	usd
CY2023Q1	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	314100000	usd
CY2022Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	362500000	usd
CY2020Q1	cg	Termination Of Tax Receivable Agreement Cost Per Partnership Unit Exchanged TerminationOfTaxReceivableAgreementCostPerPartnershipUnitExchanged	1.50
CY2020Q1	cg	Termination Of Tax Receivable Agreement Annual Installment Cost Per Partnership Unit Exchanged TerminationOfTaxReceivableAgreementAnnualInstallmentCostPerPartnershipUnitExchanged	0.30
CY2020Q1	cg	Termination Of Tax Receivable Agreement Obligation Discount TerminationOfTaxReceivableAgreementObligationDiscount	11300000	usd
CY2023Q1	cg	Percentage Of Estimated Realizable Tax Benefit To Be Paid By Corporate Taxpayers On Exchange Transactions PercentageOfEstimatedRealizableTaxBenefitToBePaidByCorporateTaxpayersOnExchangeTransactions	0.85
CY2023Q1	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	400000	usd
CY2022Q1	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	100000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	34300000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	147900000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.21
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.20
CY2023Q1	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	33900000	usd
CY2022Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	39700000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	636700000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	600300000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	24600000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	23200000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	100700000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	100700000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	362944260	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	365357833	shares
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	80400000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.28
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.28
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	571600000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	571600000	usd
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	357574838	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	363010282	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.60
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.57
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	362944260	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	365357833	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	357574838	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	363010282	shares
CY2021Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	400000000	usd
CY2023Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	500000000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	100300000	usd
	us-gaap	Distribution Made To Limited Partner Distributions Paid Per Unit DistributionMadeToLimitedPartnerDistributionsPaidPerUnit	1.30
CY2023Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	500000000	usd
CY2021Q4	cg	Realized Performance Allocations And Incentive Fee Related Compensation Percentage RealizedPerformanceAllocationsAndIncentiveFeeRelatedCompensationPercentage	0.20
CY2023Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation Gross StockIssuedDuringPeriodSharesShareBasedCompensationGross	0	shares
CY2022Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation Gross StockIssuedDuringPeriodSharesShareBasedCompensationGross	636461	shares
CY2022Q1	cg	Realized Performance Allocations And Incentive Fee Related Compensation RealizedPerformanceAllocationsAndIncentiveFeeRelatedCompensation	31300000	usd
CY2022Q2	us-gaap	Distribution Made To Limited Partner Distributions Paid Per Unit DistributionMadeToLimitedPartnerDistributionsPaidPerUnit	0.325
CY2022Q2	us-gaap	Distribution Made To Limited Partner Cash Distributions Paid DistributionMadeToLimitedPartnerCashDistributionsPaid	117600000	usd
CY2022Q3	us-gaap	Distribution Made To Limited Partner Distributions Paid Per Unit DistributionMadeToLimitedPartnerDistributionsPaidPerUnit	0.325
CY2022Q3	us-gaap	Distribution Made To Limited Partner Cash Distributions Paid DistributionMadeToLimitedPartnerCashDistributionsPaid	118300000	usd
CY2022Q4	us-gaap	Distribution Made To Limited Partner Distributions Paid Per Unit DistributionMadeToLimitedPartnerDistributionsPaidPerUnit	0.325
CY2022Q4	us-gaap	Distribution Made To Limited Partner Cash Distributions Paid DistributionMadeToLimitedPartnerCashDistributionsPaid	118200000	usd
CY2023Q1	us-gaap	Distribution Made To Limited Partner Distributions Paid Per Unit DistributionMadeToLimitedPartnerDistributionsPaidPerUnit	0.325
CY2023Q1	us-gaap	Distribution Made To Limited Partner Cash Distributions Paid DistributionMadeToLimitedPartnerCashDistributionsPaid	118400000	usd
	us-gaap	Distribution Made To Limited Partner Cash Distributions Paid DistributionMadeToLimitedPartnerCashDistributionsPaid	472500000	usd
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	16000000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	3527870	shares
CY2023Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	63849	shares
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2022Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2022Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023Q1	us-gaap	Revenues Revenues	859000000.0	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	703000000.0	usd
CY2023Q1	cg	Net Investment Gains Losses Of Consolidated Funds NetInvestmentGainsLossesOfConsolidatedFunds	3600000	usd
CY2023Q1	cg	Economic Net Income Loss Reconciliation Distributed Earnings EconomicNetIncomeLossReconciliationDistributedEarnings	159600000	usd
CY2023Q1	us-gaap	Assets Assets	21273900000	usd
CY2022Q1	us-gaap	Revenues Revenues	1581800000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	841900000	usd
CY2022Q1	cg	Net Investment Gains Losses Of Consolidated Funds NetInvestmentGainsLossesOfConsolidatedFunds	2800000	usd
CY2022Q1	cg	Economic Net Income Loss Reconciliation Distributed Earnings EconomicNetIncomeLossReconciliationDistributedEarnings	742700000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	159600000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	742700000	usd
CY2023Q1	cg	Performance Allocations And Incentive Fee Expense PerformanceAllocationsAndIncentiveFeeExpense	105700000	usd
CY2023Q1	cg	Net Realized Performance Fees NetRealizedPerformanceFees	55100000	usd
CY2022Q1	cg	Performance Allocations And Incentive Fee Expense PerformanceAllocationsAndIncentiveFeeExpense	370700000	usd
CY2022Q1	cg	Net Realized Performance Fees NetRealizedPerformanceFees	339500000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1010100000	usd
CY2023Q1	cg	Cash And Cash Equivalents At Carrying Value Held At Consolidated Funds CashAndCashEquivalentsAtCarryingValueHeldAtConsolidatedFunds	228800000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	16800000	usd
CY2023Q1	cg	Corporate Treasury Investments CorporateTreasuryInvestments	102000000.0	usd
CY2023Q1	cg	Accrued Performance Based Capital Allocation AccruedPerformanceBasedCapitalAllocation	7134000000	usd
CY2023Q1	us-gaap	Investments Investments	10784100000	usd
CY2023Q1	cg	Investments Of Consolidated Funds InvestmentsOfConsolidatedFunds	7067300000	usd
CY2023Q1	us-gaap	Due From Affiliates DueFromAffiliates	499300000	usd
CY2023Q1	cg	Due From Affiliates Of Consolidated Funds DueFromAffiliatesOfConsolidatedFunds	100600000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	141800000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	331500000	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	111100000	usd
CY2023Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	866400000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	14100000	usd
CY2023Q1	us-gaap	Assets Assets	21273900000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2275600000	usd
CY2023Q1	cg	Loan Payable To Affiliate Of Consolidated Funds LoanPayableToAffiliateOfConsolidatedFunds	6085900000	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	304800000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	3894200000	usd
CY2023Q1	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	314100000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	411700000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	389500000	usd
CY2023Q1	cg	Other Liabilities Of Consolidated Funds OtherLiabilitiesOfConsolidatedFunds	250800000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	494900000	usd
CY2023Q1	cg	Accrued Giveback Obligations AccruedGivebackObligations	40900000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	14462400000	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	3600000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3195500000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3280900000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-305200000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	636700000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6811500000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21273900000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1360700000	usd
CY2022Q4	cg	Cash And Cash Equivalents At Carrying Value Held At Consolidated Funds CashAndCashEquivalentsAtCarryingValueHeldAtConsolidatedFunds	209000000.0	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	800000	usd
CY2022Q4	cg	Corporate Treasury Investments CorporateTreasuryInvestments	20000000.0	usd
CY2022Q4	cg	Accrued Performance Based Capital Allocation AccruedPerformanceBasedCapitalAllocation	7117700000	usd
CY2022Q4	us-gaap	Investments Investments	10767900000	usd
CY2022Q4	cg	Investments Of Consolidated Funds InvestmentsOfConsolidatedFunds	6894400000	usd
CY2022Q4	us-gaap	Due From Affiliates DueFromAffiliates	579400000	usd
CY2022Q4	cg	Due From Affiliates Of Consolidated Funds DueFromAffiliatesOfConsolidatedFunds	101900000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	139900000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	337000000.0	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	78400000	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	897800000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	15800000	usd
CY2022Q4	us-gaap	Assets Assets	21403000000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2271700000	usd
CY2022Q4	cg	Loan Payable To Affiliate Of Consolidated Funds LoanPayableToAffiliateOfConsolidatedFunds	5905200000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	369200000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	4320900000	usd
CY2022Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	362500000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	126400000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	402700000	usd
CY2022Q4	cg	Other Liabilities Of Consolidated Funds OtherLiabilitiesOfConsolidatedFunds	279300000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	502900000	usd
CY2022Q4	cg	Accrued Giveback Obligations AccruedGivebackObligations	40900000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	14581700000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	3600000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3138500000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3401100000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-322200000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	600300000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6821300000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21403000000	usd
CY2023Q1	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	172500000	usd
CY2023Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	44000000.0	usd
CY2023Q1	cg	Interest And Other Income Of Consolidated Funds InterestAndOtherIncomeOfConsolidatedFunds	121900000	usd
CY2023Q1	us-gaap	Revenues Revenues	859000000.0	usd
CY2023Q1	us-gaap	Salaries And Wages SalariesAndWages	260200000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	54400000	usd
CY2023Q1	cg	Performance Allocations And Incentive Fee Expense PerformanceAllocationsAndIncentiveFeeExpense	105700000	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	420300000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	159200000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	29700000	usd
CY2023Q1	cg	Interest And Other Expenses Of Consolidated Funds InterestAndOtherExpensesOfConsolidatedFunds	93700000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-100000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	703000000.0	usd
CY2023Q1	cg	Net Investment Gains Losses Of Consolidated Funds NetInvestmentGainsLossesOfConsolidatedFunds	3600000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	159600000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	34300000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	125300000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	24600000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	100700000	usd
CY2022Q1	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	1029800000	usd
CY2022Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	25800000	usd
CY2022Q1	cg	Interest And Other Income Of Consolidated Funds InterestAndOtherIncomeOfConsolidatedFunds	61700000	usd
CY2022Q1	us-gaap	Revenues Revenues	1581800000	usd
CY2022Q1	us-gaap	Salaries And Wages SalariesAndWages	254300000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	39700000	usd
CY2022Q1	cg	Performance Allocations And Incentive Fee Expense PerformanceAllocationsAndIncentiveFeeExpense	370700000	usd
CY2022Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	664700000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	106300000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	27800000	usd
CY2022Q1	cg	Interest And Other Expenses Of Consolidated Funds InterestAndOtherExpensesOfConsolidatedFunds	42800000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-300000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	841900000	usd
CY2022Q1	cg	Net Investment Gains Losses Of Consolidated Funds NetInvestmentGainsLossesOfConsolidatedFunds	2800000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	742700000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	147900000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	594800000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	23200000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	571600000	usd

Files In Submission

Name	View Source	Status
cg-20230331_cal.xml	Edgar Link	unprocessable
0001527166-23-000064-index-headers.html	Edgar Link	pending
0001527166-23-000064-index.html	Edgar Link	pending
0001527166-23-000064.txt	Edgar Link	pending
0001527166-23-000064-xbrl.zip	Edgar Link	pending
cg-20230331.htm	Edgar Link	pending
cg-20230331.xsd	Edgar Link	pending
cg2023033110-qexhibit101.htm	Edgar Link	pending
cg202333110-q_exx22.htm	Edgar Link	pending
cg2023331exhibit104.htm	Edgar Link	pending
cg2023331exhibit105.htm	Edgar Link	pending
cg2023331exhibit106.htm	Edgar Link	pending
cg2023331exhibit311.htm	Edgar Link	pending
cg2023331exhibit312.htm	Edgar Link	pending
cg2023331exhibit321.htm	Edgar Link	pending
cg2023331exhibit322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
cg-20230331_def.xml	Edgar Link	unprocessable
cg-20230331_lab.xml	Edgar Link	unprocessable
cg-20230331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cg-20230331_htm.xml	Edgar Link	completed
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CG
Carlyle Group Inc. Stock $cg

2023 Q2 Form 10-Q Financial Statement

#000152716623000064 Filed on May 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CG Carlyle Group Inc. Stock $cg

2023 Q2 Form 10-Q Financial Statement

#000152716623000064 Filed on May 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CG
Carlyle Group Inc. Stock $cg